<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Schuur, A.G.</title>
    <link>http://repub.eur.nl/res/aut/10492/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters (Article)</title>
      <link>http://repub.eur.nl/res/pub/9872/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Polyhalogenated aromatic hydrocarbons (PHAHs), such as polychlorinated
      dibenzo-p-dioxins and dibenzofurans, polybrominated diphenylethers, and
      bisphenol A derivatives are persistent environmental pollutants, which are
      capable of interfering with reproductive and endocrine function in birds,
      fish, reptiles, and mammals. PHAHs exert estrogenic effects that may be
      mediated in part by their hydroxylated metabolites (PHAH-OHs), the
      mechanisms of which remain to be identified. PHAH-OHs show low affinity
      for the ER. Alternatively, they may exert their estrogenic effects by
      inhibiting E2 metabolism. As sulfation of E2 by estrogen sulfotransferase
      (SULT1E1) is an important pathway for E2 inactivation, inhibition of
      SULT1E1 may lead to an increased bioavailability of estrogens in tissues
      expressing this enzyme. Therefore, we studied the possible inhibition of
      human SULT1E1 by hydroxylated PHAH metabolites and the sulfation of the
      different compounds by SULT1E1. We found marked inhibition of SULT1E1 by
      various PHAH-OHs, in particular by compounds with two adjacent halogen
      substituents around the hydroxyl group that were effective at
      (sub)nanomolar concentrations. Depending on the structure, the inhibition
      is primarily competitive or noncompetitive. Most PHAH-OHs are also
      sulfated by SULT1E1. We also investigated the inhibitory effects of the
      various PHAH-OHs on E2 sulfation by human liver cytosol and found that the
      effects were strongly correlated with their inhibitions of recombinant
      SULT1E1 (r = 0.922). Based on these results, we hypothesize that
      hydroxylated PHAHs exert their estrogenic effects at least in part by
      inhibiting SULT1E1-catalyzed E2 sulfation.</description>
    </item> <item>
      <title>Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs (Article)</title>
      <link>http://repub.eur.nl/res/pub/9366/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>Polychlorinated biphenyls (PCBs) are persistent environmental pollutants
          which exert a variety of toxic effects in animals, including disturbances
          of sexual development and reproductive function. The estrogenic effects of
          PCBs may be mediated in part by hydroxylated PCB metabolites (PCB-OHs),
          but the mechanisms by which they are brought about are not understood.
          PCBs as well as PCB-Hs show low affinities for both alpha and beta
          estrogen receptor isoforms. In the present study we demonstrate that
          various environmentally relevant PCB-OHs are extremely potent inhibitors
          of human estrogen sulfotransferase, strongly suggesting that they
          indirectly induce estrogenic activity by increasing estradiol
          bioavailability in target tissues.</description>
    </item>
  </channel>
</rss>